Total Payments
$15,524
2024 Payments
$3,341
Companies
18
Transactions
776
Medicare Patients
815
Medicare Billing
$59,593
Payment Breakdown by Category
Food & Beverage$15,103 (97.3%)
Education$420.79 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,103 | 769 | 97.3% |
| Education | $420.79 | 7 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $2,867 | 132 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $2,529 | 138 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,066 | 93 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,386 | 68 | $0 (2024) |
| ABBVIE INC. | $1,198 | 64 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,134 | 76 | $0 (2022) |
| ITI, Inc. | $1,024 | 38 | $0 (2023) |
| Lundbeck LLC | $939.67 | 49 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $838.08 | 36 | $0 (2024) |
| Indivior Inc. | $412.61 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,341 | 141 | Teva Pharmaceuticals USA, Inc. ($949.30) |
| 2023 | $3,345 | 145 | Alkermes, Inc. ($621.49) |
| 2022 | $3,186 | 132 | Teva Pharmaceuticals USA, Inc. ($674.89) |
| 2021 | $1,564 | 84 | Alkermes, Inc. ($512.01) |
| 2020 | $829.47 | 61 | Alkermes, Inc. ($238.15) |
| 2019 | $1,509 | 90 | Sunovion Pharmaceuticals Inc. ($440.02) |
| 2018 | $1,023 | 68 | Sunovion Pharmaceuticals Inc. ($224.04) |
| 2017 | $726.02 | 55 | Alkermes, Inc. ($252.29) |
All Payment Transactions
776 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: CNS | ||||||
| 12/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: Central Nervous System | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $131.53 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.32 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $6.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $3.37 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| 11/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $108.02 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/12/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Neurology | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: CNS | ||||||
| 10/30/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Neuropsychiatry | ||||||
| 10/23/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 170 | 348 | $21,896 | $12,646 |
| 2022 | 4 | 192 | 428 | $26,135 | $15,485 |
| 2021 | 3 | 208 | 401 | $20,156 | $12,573 |
| 2020 | 3 | 245 | 477 | $30,646 | $18,890 |
Total Patients
815
Total Services
1,654
Medicare Billing
$59,593
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 68 | 135 | $9,025 | $5,342 | 59.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 26 | 50 | $4,925 | $2,899 | 58.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 60 | 145 | $5,398 | $2,683 | 49.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 18 | $2,548 | $1,721 | 67.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 74 | 192 | $12,866 | $7,463 | 58.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 71 | 177 | $6,511 | $3,452 | 53.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 31 | 37 | $3,600 | $2,397 | 66.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 16 | 22 | $3,158 | $2,173 | 68.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 67 | 137 | $8,910 | $6,171 | 69.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 68 | 152 | $5,126 | $3,104 | 60.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 30 | $2,871 | $2,129 | 74.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 24 | $1,495 | $639.30 | 42.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 36 | 58 | $1,754 | $530.20 | 30.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 81 | 199 | $10,089 | $6,844 | 67.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 74 | $5,768 | $4,158 | 72.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 53 | 82 | $6,926 | $3,900 | 56.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 54 | 104 | $5,566 | $2,854 | 51.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 14 | 18 | $2,297 | $1,132 | 49.3% |
About Dr. Mary Tyson, M.D
Dr. Mary Tyson, M.D is a Psychiatry healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780669218.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Tyson, M.D has received a total of $15,524 in payments from pharmaceutical and medical device companies, with $3,341 received in 2024. These payments were reported across 776 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($15,103).
As a Medicare-enrolled provider, Tyson has provided services to 815 Medicare beneficiaries, totaling 1,654 services with total Medicare billing of $59,593. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Augusta, GA
- Active Since 12/07/2005
- Last Updated 10/21/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1780669218
Products in Payments
- ARISTADA (Drug) $2,437
- INVEGA SUSTENNA (Drug) $1,833
- VRAYLAR (Drug) $1,599
- CAPLYTA (Drug) $1,227
- LATUDA (Drug) $1,134
- REXULTI (Drug) $1,075
- ABILIFY MAINTENA (Drug) $1,062
- AUSTEDO (Drug) $921.93
- INGREZZA (Drug) $838.08
- UZEDY (Drug) $604.58
- Austedo XR (Drug) $558.51
- PERSERIS (Drug) $412.61
- Aristada 441 mg (Drug) $347.80
- Auvelity (Drug) $204.40
- INVEGA TRINZA (Drug) $200.11
- COBENFY (Drug) $131.53
- BRINTELLIX (Drug) $95.96
- ABILIFY ASIMTUFII (Drug) $92.46
- Trintellix (Drug) $65.57
- OSMOLEX ER (Drug) $44.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Augusta
Joseph Mcevoy, Md, MD
Psychiatry — Payments: $113,605
Psychiatry $113,605
Dr. William Mccall, Md, MD
Psychiatry — Payments: $69,198
Psychiatry $69,198
Dr. Prakash Merai, M.d, M.D
Psychiatry — Payments: $13,057
Psychiatry $13,057
Elizabeth Messulam, Md, MD
Psychiatry — Payments: $11,031
Psychiatry $11,031
Dr. Brian Miller, M.d, M.D
Psychiatry — Payments: $9,544
Psychiatry $9,544
Peter Rosenquist, Md, MD
Psychiatry — Payments: $8,739
Psychiatry $8,739